2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Type2diabetes: new trials by email Literature Review of Type2diabetes trials Research Report on Type2diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients Fuling Yunhua Granules, Dihuang Baoyuan Granules, Fuling Yunhua Granules matched placebo/Dihuang Baoyuan Granules matched placebo - Diabetes Mellitus, Type 2, Diabetes | Phase 2 | Completed | Beijing Supreme Life Pharmaceutical Technology Co., Ltd. | 95 | 2024-07-31 | 2026-10-05 |
| The Effects of Glucagon on Hepatic Metabolism Glucagon response study - Obesity, Type2diabetes | Phase 1 / Phase 2 | Completed | Adrian Vella | 21 | 2022-10-20 | 2026-11-04 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Fatty Liver (1) · Insulin Resistance (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1)
Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Body Weight (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Hyperinsulinism (1) · Liver Diseases (1) · Nutrition Disorders (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Glucagon (1)
Adrian Vella (1) · Beijing Supreme Life Pharmaceutical Technology Co., Ltd. (1)
China (1) · United States (1)
Adrian Vella (1)
R01DK116231 (1)